Powerful forces are converging in US health care to finally cause recognition of the inherently logical relationship between quality and money. The forces, or marketplace "drivers," which are converging to compel recognition of the relationship between cost and quality are: (1) the increasing costs of care; (2) the recurrence of another medical malpractice crisis; and (3) the recognition inside...

New therapies are incorporated into clinical practice for a variety of reasons. Usually, they are more efficacious than what is currently used for a specific disease state. Sometimes, they are just as efficacious but safer. When a new treatment strategy is able to achieve better efficacy and safety, at an equal or lower cost, it becomes a “dominant” strategy. Few therapies in cardiovascular med...

The American Society for Clinical Investigation has supported the career development of physician-scientists for the past 100 years. As the ASCI looks to its next 100 years, it must be a leading force, not only for advancing the research of physician-scientists, but also for stimulating public advocacy for biomedical research in this country.

It has become fairly common to hear the term “value proposition”. It is often featured as a component of a sales and marketing strategy in various ways, such as: advertisements, white papers, case studies or within sales collateral. In fact, the term has become quite familiar, yet when a series of value propositions are evaluated it becomes clear that not all value props are created equally. In...